Earnings Central
featured
The second-largest drugmaker in the U.S. said it earned 46 cents per share, compared with 49 cents per share in the same period a year ago.
» Read More
More
-
Netflix surprised the market with an unexpected profit. Its revenue and outlook also topped forecasts. Shares jumped more than 25 percent after-hours.
-
Ben Reitzes, Barclays analyst, provides a preview of the tech giant's quarterly numbers and discusses whether Apple is ready to step up its web services.
-
Apple earnings will give investors two things to watch: iPhone sales and gross margins, Toni Sacconaghi of Sanford Bernstein says.
-
Upscale leather-goods maker and retailer Coach reported holiday quarter revenue below Wall Street forecasts amid a tough economy and stiff competition.
-
R.J. Hottovy, Morningstar senior restaurant analyst, reviews McDonald's fourth quarter numbers, and explains why the company is focusing on its "dollar menu."
-
Starbucks' caffeinated performance is expected to continue when the coffee giant reports earnings Thursday.
-
United Technologies reported earnings Wednesday that topped expectations, but profit declined amid large restructuring charges that saw the company close its largest-ever acquisition and sell several small units.
-
Advanced Micro Devices shares soared Wednesday after the chipmaker beat market expectations for its fourth quarter earnings. THE SPARK: The company reported after the market closed Tuesday that it lost $473 million or 63 cents per share for the quarter, compared with a loss of $177 million, or 24 cents per share, in the same quarter last year.
-
Jan 23- US Airways Group Inc, which has pushed hard for a merger with bankrupt AMR Corp's American Airlines, on Wednesday reported a rise in quarterly profit as higher revenue offset cost increases.
-
WASHINGTON-- Abbott Laboratories said Wednesday its profit fell 35 percent in the fourth quarter on costs from the spin-off of its drug business into the new company Abbvie. Abbvie will market the company's branded prescription drugs, including the blockbuster anti-inflammatory drug Humira.
-
Google reported fourth-quarter earnings that beat expectations, while revenue fell slightly short and its advertising rates fell less than in previous quarters. Shares rose after-hours.
-
DANBURY, Conn.-- Praxair's net income slipped 1 percent in the fourth quarter, pressured by unfavorable foreign currency exchange and soft economic conditions globally. Praxair earned $414 million, or $1.38 per share, for the period ended Dec. 31.
-
The chip maker posted fourth-quarter earnings that beat analyst estimates, but warned that it's first-quarter results will miss forecasts.
-
IBM reported quarterly earnings and revenue Tuesday that exceeded analysts' predictions. Shares rose after-hours.
-
The Atlanta company still beat Wall Street expectations, which has watched the environment in the energy sector shift rapidly. RPC earned $55.4 million, or 26 cents per share, down from $74.6 million, or 34 cents per share, in the same quarter last year. Revenue fell 3 percent to $469.9 million from $482.8 million.
-
Jan 23- Diversified U.S. manufacturer Textron Inc posted quarterly earnings that topped analysts' forecasts and set a 2013 profit target that at its midpoint would represent growth of about 12 percent.
-
JACKSON, Miss.-- Regional bank Trustmark Corp. said profit in 2012' s fourth quarter rose 14 percent from the same three months of 2011, as bad loans fell and the bank made more from writing new mortgages. Trustmark said Tuesday it made a quarterly profit of $27.7 million, or 43 cents per share, up from $24.3 million, or 38 cents per share, in 2011' s fourth quarter.
-
Verizon shares dropped in pre-open trading after the company reported a fourth-quarter loss per share of $1.48.
-
Even though it is widely viewed to be undervalued Apple shareholders could still be in for more rough times if technical strategists are right.
-
Johnson & Johnson reported earnings Tuesday that topped analysts' expectations, though revenue was in line with estimates.